Date: October 11-15, 2002
Location: St. Petersburg Beach, Florida, USA
Symposium Web Page: www.moffitt.usf.edu/promotions/molecular/index.htm
Sponsors: H. Lee Moffitt Cancer Center & Research Institute
Topics: The purpose of this meeting is to foster exchange of the most recent findings and ideas in cancer biology. Special emphasis will be placed on bridging basic science and clinical research to create new collaborations between disciplines. Conference will include keynote speaker reception and dinner, session lectures, short talks, call for abstract and poster session, vendor exhibits and several meal functions. Free time has been set aside for networking with colleagues from around the world.
Continuing Education: Yes
Aug 1, 2014 - In patients with drug-resistant chronic myeloid leukemia, two second-line drugs -- nilotinib and dasatinib -- may be at least as effective as the front-line drug imatinib, according to research presented this week at the annual meeting of the American Society of Hematology, held from Dec. 5 to 8 in New Orleans.